Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023

•   Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting •   Execution of strategic...

Related Keywords

New York ,United States ,France ,Paris ,France General ,Maryland ,North Carolina ,Baltimore ,Raleigh ,French ,American ,Bingc Wang ,Pascalyne Wilson ,Arthur Stril ,Allogene Allo ,Annick Schwebig ,Ashleyr Robinson ,Marc Dunoyer ,Patricia Sosa Navarro ,American Society Of Gene ,Taz Holdings ,European Hematology Association ,Calyxt Inc ,Raz Holding ,Methods Clinical Development ,Securities Exchange Commission ,American Society Of Hematology ,Society For Immunotherapy Of Cancer ,Nasdaq ,Additional Ordinary Shares Of The Company ,Cibus Global ,Group Share ,International Financial Reporting Standards ,European Investment Bank ,Astrazeneca Holdings Az ,Astrazeneca ,Cibus Inc ,European Society Of Gene ,Allogeneic Car Development Programs ,Barclays Capital Inc ,American Association For Cancer Research ,Research Data Preclinical Programs ,International Accounting Standards Board ,International Society For Cell ,Cellectis The Company Euronext Growth ,American Society ,Cellecti Board ,Euronext Growth ,Annual Meeting ,Cell Therapy ,Editing Process ,Gene Correction ,Gene Insertion ,Molecular Therapy ,American Association ,Cancer Research ,International Society ,Gene Therapy ,European Society ,Frontiers Bioengineering ,Clinical Development ,Investment Agreements ,Collaboration Agreement ,Astrazeneca Ireland ,Initial Investment Agreement ,Astrazeneca Holdings ,Subsequent Investment ,Subsequent Investment Agreement ,Additional Investment ,Initial Investment ,Tyrell Rivers ,Chronic Lymphocytic Leukemia ,Annual Report ,Depository Shares ,Cibus Merger ,Finance Contract ,Astrazeneca Initial Investment ,Astrazeneca Collaboration Agreement ,Net Income ,Regarding Use ,Nasdaq Global Market ,Private Securities Litigation Reform Act ,Sosa Navarro ,Chief Business Officer ,Lifesci Advisors ,Chief Financial Officer ,Markets ,